OTCMKTS:ECIA Encision (ECIA) Stock Price, News & Analysis $0.21 +0.00 (+0.48%) As of 03:57 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartEarningsSEC FilingsShort InterestBuy This Stock About Encision Stock (OTCMKTS:ECIA) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Encision alerts:Sign Up Key Stats Today's Range$0.21▼$0.3250-Day Range$0.21▼$0.3752-Week Range$0.21▼$0.50Volume10,100 shsAverage Volume3,441 shsMarket Capitalization$2.51 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Encision Inc., a medical device company, designs, develops, manufactures, and markets patented surgical instruments in the United States. The company provides active electrode monitoring (AEM) surgical instruments and monitors that enhance patient safety and patient outcomes in laparoscopic surgical procedures. Its AEM instruments product line comprises a range of endo-mechanical instruments, including scissors, graspers, and dissectors, as well as fixed-tip electrodes and suction-irrigation electrodes. The company also offers various handles, which are used for advanced laparoscopic procedures that incorporate stiffer shafts and ergonomic features; and AEM EndoShield 2 burn protection systems, as well as markets AEM monitor product line that is used in conjunction with AEM instruments. The company sells its products through a network of direct and independent sales representatives. Encision Inc. was incorporated in 1991 and is based in Boulder, Colorado. Read More Receive ECIA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Encision and its competitors with MarketBeat's FREE daily newsletter. Email Address ECIA Stock News HeadlinesEncision Completes $500,000 Private Placement of SharesAugust 22 at 6:50 AM | tipranks.comEncision, Inc.: Encision Reports First Quarter Fiscal Year 2026 ResultsAugust 16, 2025 | finanznachrichten.deCould This Be the End of Retirement Worries?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boom. For retirees, that could mean a way to generate reliable monthly income—without the outdated 4% withdrawal rule, risky trading, or high-fee annuities. If you’re ready to stop worrying about money running out and start enjoying the freedom to cover expenses, treat loved ones, and live life on your terms, this may be exactly what you’ve been waiting for.August 22 at 2:00 AM | Investors Alley (Ad)Encision Inc. Delays Q2 2025 Financial ReportAugust 15, 2025 | tipranks.comEncision, Inc.: Encision Reports Fourth Quarter Fiscal Year 2025 ResultsJuly 11, 2025 | finanznachrichten.deEncision Inc. Delays Filing of Yearly ReportJune 30, 2025 | tipranks.comEncision, Inc.: Encision Reports Third Quarter Fiscal Year 2025 ResultsFebruary 15, 2025 | finanznachrichten.deEncision, Inc.: Encision Reports Second Quarter Fiscal Year 2025 ResultsNovember 15, 2024 | finanznachrichten.deSee More Headlines ECIA Stock Analysis - Frequently Asked Questions How have ECIA shares performed this year? Encision's stock was trading at $0.45 at the beginning of 2025. Since then, ECIA stock has decreased by 53.1% and is now trading at $0.2110. How were Encision's earnings last quarter? Encision Inc. (OTCMKTS:ECIA) issued its earnings results on Thursday, July, 10th. The medical device company reported ($0.01) EPS for the quarter. The medical device company earned $1.58 million during the quarter. Encision had a negative trailing twelve-month return on equity of 16.99% and a negative net margin of 4.34%. How do I buy shares of Encision? Shares of ECIA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Encision own? Based on aggregate information from My MarketBeat watchlists, some other companies that Encision investors own include Akers Biosciences (AKER), MGT Capital Investments (MGTI), Brainstorm Cell Therapeutics (BCLI), Aviat Networks (AVNW), Activision Blizzard (ATVI), ATI (ATI) and Digital Turbine (APPS). Company Calendar Last Earnings7/10/2025Today8/22/2025Fiscal Year End3/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry MED INSTRUMENTS Sub-IndustryMedical Equipment Current SymbolOTCMKTS:ECIA CIK930775 Webwww.encision.com Phone(303) 444-2600Fax303-444-2693Employees30Year FoundedN/AProfitability EPS (Trailing Twelve Months)($0.02) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$220 thousand Net Margins-4.34% Pretax Margin-4.34% Return on Equity-16.99% Return on Assets-7.45% Debt Debt-to-Equity Ratio0.10 Current Ratio1.92 Quick Ratio0.72 Sales & Book Value Annual Sales$6.55 million Price / Sales0.38 Cash FlowN/A Price / Cash FlowN/A Book Value$0.14 per share Price / Book1.51Miscellaneous Outstanding Shares11,880,000Free Float7,514,000Market Cap$2.51 million OptionableNot Optionable Beta0.65 7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleLooking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.Get This Free Report This page (OTCMKTS:ECIA) was last updated on 8/22/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredA grave, grave error.Nvidia just shattered records—hitting $4 trillion in valuation faster than any company in history. But one ...Porter & Company | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Encision Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Encision With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.